Search details
1.
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.
Cell
; 174(2): 433-447.e19, 2018 07 12.
Article
in English
| MEDLINE | ID: mdl-29909985
2.
A pan-cancer transcriptome analysis of exitron splicing identifies novel cancer driver genes and neoepitopes.
Mol Cell
; 81(10): 2246-2260.e12, 2021 05 20.
Article
in English
| MEDLINE | ID: mdl-33861991
3.
Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling.
Proc Natl Acad Sci U S A
; 120(17): e2218522120, 2023 04 25.
Article
in English
| MEDLINE | ID: mdl-37068243
4.
Androgen receptor variants: RNA-based mechanisms and therapeutic targets.
Hum Mol Genet
; 29(R1): R19-R26, 2020 09 30.
Article
in English
| MEDLINE | ID: mdl-32412639
5.
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
Proc Natl Acad Sci U S A
; 116(2): 631-640, 2019 01 08.
Article
in English
| MEDLINE | ID: mdl-30578319
6.
iRGD-liposomes enhance tumor delivery and therapeutic efficacy of antisense oligonucleotide drugs against primary prostate cancer and bone metastasis.
Adv Funct Mater
; 31(24)2021 Jun 09.
Article
in English
| MEDLINE | ID: mdl-34211360
7.
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities.
Nucleic Acids Res
; 47(11): 5634-5647, 2019 06 20.
Article
in English
| MEDLINE | ID: mdl-31006810
8.
Androgen Receptor Dependence.
Adv Exp Med Biol
; 1210: 333-350, 2019.
Article
in English
| MEDLINE | ID: mdl-31900916
9.
Indel detection from DNA and RNA sequencing data with transIndel.
BMC Genomics
; 19(1): 270, 2018 Apr 19.
Article
in English
| MEDLINE | ID: mdl-29673323
10.
Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival.
Prostate
; 78(15): 1140-1156, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30009471
11.
Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
Prostate
; 77(6): 584-596, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28144973
12.
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.
Nucleic Acids Res
; 43(12): 5880-97, 2015 Jul 13.
Article
in English
| MEDLINE | ID: mdl-25908785
13.
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.
Proc Natl Acad Sci U S A
; 110(43): 17492-7, 2013 Oct 22.
Article
in English
| MEDLINE | ID: mdl-24101480
14.
SHEAR: sample heterogeneity estimation and assembly by reference.
BMC Genomics
; 15: 84, 2014 Jan 29.
Article
in English
| MEDLINE | ID: mdl-24476358
15.
Androgen receptor and estrogen receptor variants in prostate and breast cancers.
J Steroid Biochem Mol Biol
; 241: 106522, 2024 Apr 17.
Article
in English
| MEDLINE | ID: mdl-38641298
16.
Evolving copy number gains promote tumor expansion and bolster mutational diversification.
Nat Commun
; 15(1): 2025, 2024 Mar 06.
Article
in English
| MEDLINE | ID: mdl-38448455
17.
Stat5 induces androgen receptor (AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling.
Sci Adv
; 10(9): eadi2742, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38416822
18.
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target across Human Malignancies.
Cancer Res Commun
; 2024 May 06.
Article
in English
| MEDLINE | ID: mdl-38709075
19.
Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.
J Biol Chem
; 287(23): 19736-49, 2012 Jun 01.
Article
in English
| MEDLINE | ID: mdl-22532567
20.
FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
Prostate
; 73(10): 1017-27, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23389878